
Daclatasvir 60 mg (Natdac) is an antiviral medicine used to treat chronic hepatitis C virus (HCV) infection. It is prescribed in combination with other antiviral medicines, such as sofosbuvir, to help eliminate the virus from the body. Daclatasvir may help reduce further liver damage and lower the risk of serious complications associated with chronic hepatitis C when taken as prescribed.
| Generic name | Daclatasvir |
| Strength | 60 mg |
| Manufacturer | Natco Pharma |
| Package size | 28 Tablets |
| Used for | Chronic hepatitis C virus (HCV) infection |
| Availability | In Stock |
| Shipping to | USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, UAE, Georgia, Armenia, Saudi Arabia, Qatar, Kuwait, South Africa, and many other countries. |
Daclatasvir is a direct-acting antiviral medicine that inhibits the NS5A protein, which the hepatitis C virus needs to replicate and assemble new viral particles. By blocking this protein, daclatasvir prevents the virus from multiplying and helps clear the infection when used with other prescribed antiviral medicines.